Medicare Enrolled

Dr. Amrik Ray, M.D.

Pulmonary Disease · Elk Grove Village, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
800 BIESTERFIELD RD STE 510, Elk Grove Village, IL 60007
8479813660
In practice since 2012 (14 years)
NPI: 1114283041 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ray from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ray? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ray

Dr. Amrik Ray is a pulmonary disease specialist in Elk Grove Village, IL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Ray performed 1,146 Medicare services across 788 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ray received a total of $13,557 from 30 pharmaceutical and/or device companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ray is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 37% volume in IL $13,557 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,146
Medicare services
Top 37% in IL for pulmonary disease
788
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
527 $94 $326
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
144 $134 $477
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
122 $136 $633
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
60 $171 $792
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $95 $307
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
34 $34 $248
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
34 $44 $315
New patient office visit, complex (60-74 min) 28 $171 $605
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
19 $43 $1,097
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
19 $21 $190
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
18 $85 $1,754
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
18 $61 $322
Lung biopsy via endoscope, 1 lobe
A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination.
16 $77 $717
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
16 $30 $317
Bronchoscopy with ultrasound and growth treatment
A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found.
12 $52 $386
Insertion of chest tube for lung fluid drainage
A procedure to place a tube into the chest cavity to drain excess fluid from around the lungs.
12 $167 $1,713
Radiologist review of drainage imaging
A radiologist reviews medical images to assess the drainage of fluid.
12 $44 $474
Computer-assisted navigation of lung airways
This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation.
11 $76 $1,525
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,557
Total received (2018-2024)
Avg $1,937/year across 7 years
Top 14% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
207
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,239 (82.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,318 (17.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,864
2023
$1,152
2022
$3,198
2021
$454
2020
$104
2019
$6,352
2018
$434

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$408
GlaxoSmithKline, LLC.
$363
GENZYME CORPORATION
$295
Regeneron Healthcare Solutions, Inc.
$237
Boehringer Ingelheim Pharmaceuticals, Inc.
$122
Baxter Healthcare
$113
Electromed, Inc.
$70
Philips North America LLC
$57
Merck Sharp & Dohme LLC
$48
Mylan Specialty L.P.
$40
Janssen Pharmaceuticals, Inc
$28
Bayer Healthcare Pharmaceuticals Inc.
$23
Grifols USA, LLC
$22
Insmed, Inc.
$21
Amgen Inc.
$16
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$2,898
Intuitive Surgical, Inc.
$2,711
Covidien LP
$1,789
Pulmonx Corporation
$1,555
AstraZeneca Pharmaceuticals LP
$769
Regeneron Healthcare Solutions, Inc.
$565
GlaxoSmithKline, LLC.
$557
Pinnacle Biologics, Inc
$519
BOSTON SCIENTIFIC CORPORATION
$355
STERIS CORPORATION
$233
Electromed, Inc.
$228
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Baxter Healthcare
$193
Grifols USA, LLC
$139
ERBE USA Inc
$104
SANOFI-AVENTIS U.S. LLC
$100
Mylan Specialty L.P.
$98
COVIDIEN LP
$79
Genentech USA, Inc.
$78
Philips North America LLC
$57
PFIZER INC.
$55
Merck Sharp & Dohme LLC
$48
Inogen, Inc.
$43
Insmed, Inc.
$42
Janssen Pharmaceuticals, Inc
$28
Bayer Healthcare Pharmaceuticals Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$20
Philips Electronics North America Corporation
$19
Amgen Inc.
$16
Inspire Medical Systems, Inc.
$14
Top 3 companies account for 54.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · AREXVY · Adempas · Arikayce · BREZTRI · DIFICID · DUPIXENT · Da Vinci Surgical System · ELIQUIS · ERBE · FARXIGA · FASENRA · GENERAL THERAPIES · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · InogenOne · NUCALA · OFEV · Photofrin · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · SMARTVEST · SUPERDIMENSION · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · XARELTO · Xolair · YUPELRI · Yupelri · ZERBAXA · superDimension · truFreeze
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Elk Grove Village?
Compare pulmonary diseases in the Elk Grove Village area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
192
Per 100K population
3.7
County median income
$81,797
Nearest hospital
ALEXIAN BROTHERS MEDICAL CENTER 1
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ray is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of IL peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ray experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Ray performed 527 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ray receive payments from pharmaceutical companies?
Yes. Dr. Ray received a total of $13,557 from 30 companies across 207 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ray's costs compare to other pulmonary diseases in Elk Grove Village?
Dr. Ray's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ray) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →